{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:01:49Z","timestamp":1781053309215,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044798"],"award-info":[{"award-number":["UG3DA044798"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01461-7","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:48:28Z","timestamp":1776815308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Willingness to use a mobile syringe service program among people who inject drugs in rural Appalachia"],"prefix":"10.1186","volume":"23","author":[{"given":"Alex","family":"Elswick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Fallin-Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasfia","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Westneat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"5","key":"1461_CR1","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/s2214-109x(23)00057-8","volume":"11","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Webb P, Colledge-Frisby S, et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e659\u201372. https:\/\/doi.org\/10.1016\/s2214-109x(23)00057-8.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"1461_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s2468-1253(23)00018-3","volume":"8","author":"A Artenie","year":"2023","unstructured":"Artenie A, Stone J, Fraser H, et al. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):533\u201352. https:\/\/doi.org\/10.1016\/s2468-1253(23)00018-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1461_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1891\/2168-6653.33.1.56","volume":"33","author":"BJ Kim","year":"2019","unstructured":"Kim BJ, Harley DA. Needle and syringe programs in rural areas: Addressing the intravenous drug use epidemic. Rehabil Res Policy Educ. 2019;33(1):56\u201364. https:\/\/doi.org\/10.1891\/2168-6653.33.1.56.","journal-title":"Rehabil Res Policy Educ"},{"issue":"6","key":"1461_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40480","volume":"15","author":"S Rengifo","year":"2023","unstructured":"Rengifo S, Wu A, Ioffreda P, Ilyas AM. Differences in Opioid-Related Deaths in the Appalachian Region in 2018\u20132021 by State and Rural-Urban County Classification. Cureus. 2023;15(6):e40480. https:\/\/doi.org\/10.7759\/cureus.40480.","journal-title":"Cureus"},{"issue":"1","key":"1461_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/00914150231171856","volume":"98","author":"KM Hash","year":"2024","unstructured":"Hash KM, Schreurs BG, Tolley SM, Fiske A. Health disparities in Appalachian and other rural communities. Int J Aging Hum Dev. 2024;98(1):56\u201368.","journal-title":"Int J Aging Hum Dev"},{"issue":"23","key":"1461_CR6","doi-asserted-by":"publisher","first-page":"12792","DOI":"10.3390\/ijerph182312792","volume":"18","author":"KM Cardarelli","year":"2021","unstructured":"Cardarelli KM, DeWitt E, Gillespie R, Graham RH, Norman-Burgdolf H, Mullins JT. Policy Implications of the COVID-19 Pandemic on Food Insecurity in Rural America: Evidence from Appalachia. Int J Environ Res Public Health. 2021;18(23):12792.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"1461_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1353\/hpu.2024.a943985","volume":"35","author":"J Bailey","year":"2024","unstructured":"Bailey J, Burchfield K, Redden J, et al. The Road to Access: Addressing Transportation Challenges in Rural Primary Care. J Health Care Poor Underserved. 2024;35(4):1192\u2013205.","journal-title":"J Health Care Poor Underserved"},{"key":"1461_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/15332640.2024.2316650","author":"CL Sedney","year":"2024","unstructured":"Sedney CL, Dekeseredy P, Anderson P, Haggerty T. \u201cThey either leave you or they get involved in it\u201d: familial factors influencing drug use amongst Appalachian people. J Ethn Subst Abuse. 2024. https:\/\/doi.org\/10.1080\/15332640.2024.2316650.","journal-title":"J Ethn Subst Abuse"},{"key":"1461_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.11.001","volume":"85","author":"M Fadanelli","year":"2020","unstructured":"Fadanelli M, Cloud DH, Ibragimov U, et al. People, places, and stigma: a qualitative study exploring the overdose risk environment in rural Kentucky. Int J Drug Policy. 2020;85:102588.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1461_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/dyt243","volume":"43","author":"EJ Aspinall","year":"2014","unstructured":"Aspinall EJ, Nambiar D, Goldberg DJ, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235\u201348. https:\/\/doi.org\/10.1093\/ije\/dyt243.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"1461_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.18553\/jmcp.2021.27.2.137","volume":"27","author":"SC Ijioma","year":"2021","unstructured":"Ijioma SC, Pontinha VM, Holdford DA, Carroll NV. Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree. J Manag Care Spec Pharm. 2021;27(2):137\u201346. https:\/\/doi.org\/10.18553\/jmcp.2021.27.2.137.","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"1461_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0740-5472(00)00104-5","volume":"19","author":"H Hagan","year":"2000","unstructured":"Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19(3):247\u201352. https:\/\/doi.org\/10.1016\/S0740-5472(00)00104-5.","journal-title":"J Subst Abuse Treat"},{"key":"1461_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104422","volume":"128","author":"T Jahangir","year":"2024","unstructured":"Jahangir T, Fuller GK, Livingston MD, et al. Syringe reuse among people who inject drugs in rural Appalachian Kentucky. Int J Drug Policy. 2024;128:104422. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104422.","journal-title":"Int J Drug Policy"},{"key":"1461_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102821","volume":"83","author":"TS Bartholomew","year":"2020","unstructured":"Bartholomew TS, Nakamura N, Metsch LR, Tookes HE. Syringe services program (SSP) operational changes during the COVID-19 global outbreak. Int J Drug Policy. 2020;83:102821. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102821.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1461_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.annemergmed.2020.11.008","volume":"77","author":"W Macias-Konstantopoulos","year":"2021","unstructured":"Macias-Konstantopoulos W, Heins A, Sachs CJ, Whiteman PJ, Wingkun NG, Riviello RJ. Between emergency department visits: the role of harm reduction programs in mitigating the harms associated with injection drug use. Ann Emerg Med. 2021;77(5):479\u201392. https:\/\/doi.org\/10.1016\/j.annemergmed.2020.11.008.","journal-title":"Ann Emerg Med"},{"issue":"12","key":"1461_CR16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2105\/ajph.92.12.1915","volume":"92","author":"LE Grau","year":"2002","unstructured":"Grau LE, Arevalo S, Catchpool C, Heimer R. Expanding harm reduction services through a wound and abscess clinic. Am J Public Health. 2002;92(12):1915\u20137. https:\/\/doi.org\/10.2105\/ajph.92.12.1915.","journal-title":"Am J Public Health"},{"issue":"33","key":"1461_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.15585\/mmwr.mm6933a2","volume":"69","author":"BH Lambdin","year":"2020","unstructured":"Lambdin BH, Bluthenthal RN, Wenger LD, et al. Overdose education and naloxone distribution within syringe service programs - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):1117\u201321. https:\/\/doi.org\/10.15585\/mmwr.mm6933a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1461_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-023-00394-x","volume":"18","author":"A Jakubowski","year":"2023","unstructured":"Jakubowski A, Fowler S, Fox AD. Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature. Addict Sci Clin Pract. 2023;18(1):40. https:\/\/doi.org\/10.1186\/s13722-023-00394-x.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"1461_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00518-z","volume":"18","author":"U Ibragimov","year":"2021","unstructured":"Ibragimov U, Cooper KE, Batty E, et al. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky. Harm Reduct J. 2021;18(1):68. https:\/\/doi.org\/10.1186\/s12954-021-00518-z.","journal-title":"Harm Reduct J"},{"issue":"14","key":"1461_CR20","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1080\/10826084.2020.1800741","volume":"55","author":"KE Lancaster","year":"2020","unstructured":"Lancaster KE, Cooper HLF, Browning CR, Malvestutto CD, Bridges JFP, Young AM. Syringe service program utilization, barriers, and preferences for design in rural Appalachia: differences between men and women who inject drugs. Subst Use Misuse. 2020;55(14):2268\u201377. https:\/\/doi.org\/10.1080\/10826084.2020.1800741.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1461_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1037\/rmh0000248","volume":"48","author":"AM Wilson","year":"2024","unstructured":"Wilson AM, Brown AR. Barriers to utilizing substance use disorder treatment and harm reduction services in Appalachia. J Rural Ment Health. 2024;48(1):15\u201325. https:\/\/doi.org\/10.1037\/rmh0000248.","journal-title":"J Rural Ment Health"},{"issue":"3","key":"1461_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-083983","volume":"14","author":"AM Young","year":"2024","unstructured":"Young AM, Havens JR, Cooper HLF, et al. Kentucky Outreach Service Kiosk (KyOSK) study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk on HIV, HCV and overdose risk in rural Appalachia. BMJ Open. 2024;14(3):e083983. https:\/\/doi.org\/10.1136\/bmjopen-2024-083983.","journal-title":"BMJ Open"},{"issue":"2","key":"1461_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jrh.12715","volume":"39","author":"EJ Batty","year":"2023","unstructured":"Batty EJ, Ibragimov U, Fadanelli M, et al. A qualitative analysis of rural syringe service program fidelity in Appalachian Kentucky: Staff and participant perspectives. J Rural Health. 2023;39(2):328\u201337. https:\/\/doi.org\/10.1111\/jrh.12715.","journal-title":"J Rural Health"},{"issue":"1","key":"1461_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00892-w","volume":"20","author":"AM Ballard","year":"2023","unstructured":"Ballard AM, Falk D, Greenwood H, et al. Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis. Harm Reduct J. 2023;20(1):157. https:\/\/doi.org\/10.1186\/s12954-023-00892-w.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1461_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2105\/ajph.2019.305333","volume":"110","author":"HL Surratt","year":"2020","unstructured":"Surratt HL, Cowley AM, Gulley J, et al. Syringe service program use among people who inject drugs in Appalachian Kentucky. Am J Public Health. 2020;110(1):34\u20136. https:\/\/doi.org\/10.2105\/ajph.2019.305333.","journal-title":"Am J Public Health"},{"issue":"1","key":"1461_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0212-3","volume":"15","author":"C Strike","year":"2018","unstructured":"Strike C, Miskovic M. Scoping out the literature on mobile needle and syringe programs\u2014review of service delivery and client characteristics, operation, utilization, referrals, and impact. Harm Reduct J. 2018;15(1):6.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1461_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-4-14","volume":"4","author":"MM Islam","year":"2007","unstructured":"Islam MM, Conigrave KM. Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduct J. 2007;4(1):14. https:\/\/doi.org\/10.1186\/1477-7517-4-14.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1461_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/07853890.2021.2022188","volume":"54","author":"SM Grieb","year":"2022","unstructured":"Grieb SM, Harris R, Rosecrans A, et al. Awareness, perception and utilization of a mobile health clinic by people who use drugs. Ann Med. 2022;54(1):138\u201349. https:\/\/doi.org\/10.1080\/07853890.2021.2022188.","journal-title":"Ann Med"},{"key":"1461_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108976","volume":"228","author":"L Karch","year":"2021","unstructured":"Karch L, Tobias S, Schmidt C, et al. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA. Drug Alcohol Depend. 2021;228:108976. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108976.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1461_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jamapsychiatry.2021.3716","volume":"79","author":"JB Gibbons","year":"2022","unstructured":"Gibbons JB, Stuart EA, Saloner B. Methadone on Wheels\u2014A new option to expand access to care through mobile units. JAMA Psychiat. 2022;79(3):187\u20138. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.3716.","journal-title":"JAMA Psychiat"},{"key":"1461_CR31","doi-asserted-by":"publisher","unstructured":"Pepin MD, Joseph JK, Chapman BP, et al. A mobile addiction service for community-based overdose prevention. Community Case Study. Frontiers in Public Health. 2023-July-19 2023;11https:\/\/doi.org\/10.3389\/fpubh.2023.1154813","DOI":"10.3389\/fpubh.2023.1154813"},{"key":"1461_CR32","doi-asserted-by":"publisher","unstructured":"Pinkhover A, Celata K, Baker T, Chatterjee A, Lunze K. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit. Community Case Study. Frontiers in Public Health. 2024-June-18 2024;12https:\/\/doi.org\/10.3389\/fpubh.2024.1407522","DOI":"10.3389\/fpubh.2024.1407522"},{"key":"1461_CR33","doi-asserted-by":"publisher","unstructured":"Taylor H, Curado A, Tavares J, Oliveira M, Gautier D, Maria JS. Prospective client survey and participatory process ahead of opening a mobile drug consumption room in Lisbon. Harm Reduction Journal. 2019\/08\/09 2019;16(1):49. https:\/\/doi.org\/10.1186\/s12954-019-0319-1","DOI":"10.1186\/s12954-019-0319-1"},{"key":"1461_CR34","doi-asserted-by":"publisher","unstructured":"Mema SC, Frosst G, Bridgeman J, et al. Mobile supervised consumption services in Rural British Columbia: lessons learned. Harm Reduction Journal. 2019\/01\/10 2019;16(1):4. https:\/\/doi.org\/10.1186\/s12954-018-0273-3","DOI":"10.1186\/s12954-018-0273-3"},{"key":"1461_CR35","doi-asserted-by":"publisher","unstructured":"Frost MC, Austin EJ, Corcorran MA, et al. Responding to a surge in overdose deaths: perspectives from US syringe services programs. Harm Reduction Journal. 2022\/07\/19 2022;19(1):79. https:\/\/doi.org\/10.1186\/s12954-022-00664-y","DOI":"10.1186\/s12954-022-00664-y"},{"key":"1461_CR36","doi-asserted-by":"publisher","unstructured":"Tookes HE, Bartholomew TS, Sugar SES, et al. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019\u20132020. International Journal of Drug Policy. 2024\/01\/01\/ 2024;123:104289. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104289","DOI":"10.1016\/j.drugpo.2023.104289"},{"key":"1461_CR37","doi-asserted-by":"publisher","unstructured":"Noyes E, Yeo E, Yerton M, et al. Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach. Public Health Reports\u00ae. 2021;136(3):301\u2013308. https:\/\/doi.org\/10.1177\/0033354921999396","DOI":"10.1177\/0033354921999396"},{"key":"1461_CR38","doi-asserted-by":"publisher","unstructured":"Thakarar K, Kohut M, Hutchinson R, et al. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state. Harm Reduction Journal. 2022\/07\/22 2022;19(1):80. https:\/\/doi.org\/10.1186\/s12954-022-00660-2","DOI":"10.1186\/s12954-022-00660-2"},{"key":"1461_CR39","doi-asserted-by":"publisher","unstructured":"Rosecrans A, Harris R, Saxton RE, et al. Mobile low-threshold buprenorphine integrated with infectious disease services. Journal of Substance Abuse Treatment. 2022;133https:\/\/doi.org\/10.1016\/j.jsat.2021.108553","DOI":"10.1016\/j.jsat.2021.108553"},{"key":"1461_CR40","doi-asserted-by":"publisher","unstructured":"Britton TR, Clague MR, Zagorski CM, Hill LG, Loera LJ. A wound care and immunization needs assessment for participants of a mobile syringe services program in Austin, TX. J Am Pharm Assoc (2003). Jan-Feb 2023;63(1):361\u2013365.e1. https:\/\/doi.org\/10.1016\/j.japh.2022.10.018","DOI":"10.1016\/j.japh.2022.10.018"},{"key":"1461_CR41","doi-asserted-by":"publisher","unstructured":"Robinowitz N, Smith ME, Serio-Chapman C, Chaulk P, Johnson KE. Wounds on Wheels: Implementing a Specialized Wound Clinic within an Established Syringe Exchange Program in Baltimore, Maryland. American Journal of Public Health. 2014\/11\/01 2014;104(11):2057\u20132059. https:\/\/doi.org\/10.2105\/AJPH.2014.302111","DOI":"10.2105\/AJPH.2014.302111"},{"key":"1461_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.drugpo.2015.10.011","volume":"27","author":"SSH Nazari","year":"2016","unstructured":"Nazari SSH, Noroozi M, Soori H, et al. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. Int J Drug Policy. 2016;27:127\u201331. https:\/\/doi.org\/10.1016\/j.drugpo.2015.10.011.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"1461_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/jurban\/jtg053","volume":"80","author":"FL Altice","year":"2003","unstructured":"Altice FL, Springer S, Buitrago M, Hunt DP, Friedland GH. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. J Urban Health. 2003;80(3):416\u201327. https:\/\/doi.org\/10.1093\/jurban\/jtg053.","journal-title":"J Urban Health"},{"issue":"1","key":"1461_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0740-5472(02)00343-4","volume":"24","author":"I Kuo","year":"2003","unstructured":"Kuo I, Brady J, Butler C, et al. Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance. J Subst Abuse Treat. 2003;24(1):67\u201374. https:\/\/doi.org\/10.1016\/S0740-5472(02)00343-4.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"1461_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drugalcdep.2010.07.007","volume":"113","author":"KN Deering","year":"2011","unstructured":"Deering KN, Kerr T, Tyndall MW, et al. A peer-led mobile outreach program and increased utilization of detoxification and residential drug treatment among female sex workers who use drugs in a Canadian setting. Drug Alcohol Depend. 2011;113(1):46\u201354. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.07.007.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"1461_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/070674370805300803","volume":"53","author":"M Kidorf","year":"2008","unstructured":"Kidorf M, King VL. Expanding the public health benefits of syringe exchange programs. Can J Psychiatry. 2008;53(8):487\u201395. https:\/\/doi.org\/10.1177\/070674370805300803.","journal-title":"Can J Psychiatry"},{"key":"1461_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugpo.2019.04.006","volume":"70","author":"CM Jones","year":"2019","unstructured":"Jones CM. Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S. Int J Drug Policy. 2019;70:22\u201332. https:\/\/doi.org\/10.1016\/j.drugpo.2019.04.006.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1461_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00721-6","volume":"19","author":"TS Bartholomew","year":"2022","unstructured":"Bartholomew TS, Andraka-Cristou B, Totaram RK, et al. \u201cWe want everything in a one-stop shop\u201d: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs. Harm Reduct J. 2022;19(1):133. https:\/\/doi.org\/10.1186\/s12954-022-00721-6.","journal-title":"Harm Reduct J"},{"issue":"5","key":"1461_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.drugpo.2010.02.001","volume":"21","author":"L Jones","year":"2010","unstructured":"Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. Optimal provision of needle and syringe programmes for injecting drug users: a systematic review. Int J Drug Policy. 2010;21(5):335\u201342. https:\/\/doi.org\/10.1016\/j.drugpo.2010.02.001.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1461_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00524-1","volume":"18","author":"K Thakarar","year":"2021","unstructured":"Thakarar K, Sankar N, Murray K, Lucas FL, Burris D, Smith RP. Injections and infections: understanding syringe service program utilization in a rural state. Harm Reduct J. 2021;18(1):74. https:\/\/doi.org\/10.1186\/s12954-021-00524-1.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1461_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0280-z","volume":"16","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Kravietz A, Bartholomew TS, Forrest D, Tookes HE. Baseline differences in characteristics and risk behaviors among people who inject drugs by syringe exchange program modality: an analysis of the Miami IDEA syringe exchange. Harm Reduct J. 2019;16(1):7. https:\/\/doi.org\/10.1186\/s12954-019-0280-z.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1461_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0258-2","volume":"15","author":"RD Ashford","year":"2018","unstructured":"Ashford RD, Curtis B, Brown AM. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program. Harm Reduct J. 2018;15(1):52. https:\/\/doi.org\/10.1186\/s12954-018-0258-2.","journal-title":"Harm Reduct J"},{"key":"1461_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2016.1195894","author":"A Noroozi","year":"2016","unstructured":"Noroozi A, Mirzazadeh A, Hajebi A, et al. Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran. J Subst Use. 2016. https:\/\/doi.org\/10.1080\/14659891.2016.1195894.","journal-title":"J Subst Use"},{"issue":"4","key":"1461_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216205","volume":"14","author":"EH Teshale","year":"2019","unstructured":"Teshale EH, Asher A, Aslam MV, et al. Estimated cost of comprehensive syringe service program in the United States. PLoS ONE. 2019;14(4):e0216205. https:\/\/doi.org\/10.1371\/journal.pone.0216205.","journal-title":"PLoS ONE"},{"key":"1461_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209262","volume":"159","author":"SR Peddireddy","year":"2024","unstructured":"Peddireddy SR, Livingston MD III, Young AM, et al. Willingness to utilize a mobile treatment unit in five counties at the epicenter of the US rural opioid epidemic. Journal of substance use and addiction treatment. 2024;159:209262.","journal-title":"Journal of substance use and addiction treatment"},{"issue":"1","key":"1461_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13722-022-00322-5","volume":"17","author":"RA Jenkins","year":"2022","unstructured":"Jenkins RA, Whitney BM, Nance RM, et al. The rural opioid initiative consortium description: providing evidence to understand the fourth wave of the opioid crisis. Addict Sci Clin Pract. 2022;17(1):38.","journal-title":"Addict Sci Clin Pract"},{"issue":"7","key":"1461_CR57","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/add.15291","volume":"116","author":"AM Young","year":"2021","unstructured":"Young AM, Livingston M, Vickers\u2010Smith R, Cooper HL. Emergence of wasp dope in rural Appalachian Kentucky. Addiction. 2021;116(7):1901\u20137.","journal-title":"Addiction"},{"issue":"1","key":"1461_CR58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12874-024-02206-5","volume":"24","author":"AE Rudolph","year":"2024","unstructured":"Rudolph AE, Nance RM, Bobashev G, et al. Evaluation of respondent-driven sampling in seven studies of people who use drugs from rural populations: findings from the Rural Opioid Initiative. BMC Med Res Methodol. 2024;24(1):94.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"1461_CR59","doi-asserted-by":"publisher","DOI":"10.2196\/13593","volume":"5","author":"HLF Cooper","year":"2019","unstructured":"Cooper HLF, Crawford ND, Haard\u00f6erfer R, et al. Using web-based pin-drop maps to capture activity spaces among young adults who use drugs in rural areas: cross-sectional survey. JMIR Public Health Surveill. 2019;5(4):e13593.","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"1461_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-023-00427-5","volume":"18","author":"RE Stewart","year":"2023","unstructured":"Stewart RE, Christian HP, Cardamone NC, et al. Mobile service delivery in response to the opioid epidemic in Philadelphia. Addict Sci Clin Pract. 2023;18(1):71. https:\/\/doi.org\/10.1186\/s13722-023-00427-5.","journal-title":"Addict Sci Clin Pract"},{"key":"1461_CR61","doi-asserted-by":"publisher","DOI":"10.1177\/11782218221103859","volume":"16","author":"J Dickson-Gomez","year":"2022","unstructured":"Dickson-Gomez J, Spector A, Weeks M, Galletly C, McDonald M, Green Montaque HD. \u201cYou\u2019re not supposed to be on it forever\u201d: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids. Subst Abuse Res Treat. 2022;16:11782218221103859.","journal-title":"Subst Abuse Res Treat"},{"issue":"1","key":"1461_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jrh.12503","volume":"37","author":"T Beachler","year":"2021","unstructured":"Beachler T, Zeller TA, Heo M, Lanzillotta\u2010Rangeley J, Litwin AH. Community attitudes toward opioid use disorder and medication for opioid use disorder in a rural Appalachian county. J Rural Health. 2021;37(1):29\u201334.","journal-title":"J Rural Health"},{"key":"1461_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107592","volume":"204","author":"JC Strickland","year":"2019","unstructured":"Strickland JC, Havens JR, Stoops WW. A nationally representative analysis of \u201ctwin epidemics\u201d: rising rates of methamphetamine use among persons who use opioids. Drug Alcohol Depend. 2019;204:107592.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1461_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01038-2","volume":"21","author":"R Sun","year":"2024","unstructured":"Sun R, Sauda TH, Hoopsick RA. Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine. Harm Reduct J. 2024;21(1):119.","journal-title":"Harm Reduct J"},{"issue":"6","key":"1461_CR65","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/ADM.0000000000000426","volume":"12","author":"MC Frost","year":"2018","unstructured":"Frost MC, Williams EC, Kingston S, Banta-Green CJ. Interest in getting help to reduce or stop substance use among syringe exchange clients who use opioids. J Addict Med. 2018;12(6):428\u201334.","journal-title":"J Addict Med"},{"issue":"1_suppl","key":"1461_CR66","doi-asserted-by":"publisher","first-page":"10S","DOI":"10.1177\/0033354920936233","volume":"135","author":"JM Adams","year":"2020","unstructured":"Adams JM. Making the case for syringe services programs. Public Health Rep. 2020;135(1_suppl):10S-12S.","journal-title":"Public Health Rep"},{"issue":"1","key":"1461_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-023-00394-x","volume":"18","author":"A Jakubowski","year":"2023","unstructured":"Jakubowski A, Fowler S, Fox AD. Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature. Addict Sci Clin Pract. 2023;18(1):40.","journal-title":"Addict Sci Clin Pract"},{"key":"1461_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102922","volume":"85","author":"A Greer","year":"2020","unstructured":"Greer A, Bungay V, Pauly B, Buxton J. \u2018Peer\u2019work as precarious: a qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work. Int J Drug Policy. 2020;85:102922.","journal-title":"Int J Drug Policy"},{"key":"1461_CR69","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"14","key":"1461_CR70","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1080\/10826084.2020.1800741","volume":"55","author":"KE Lancaster","year":"2020","unstructured":"Lancaster KE, Cooper HL, Browning CR, Malvestutto CD, Bridges JF, Young AM. Syringe service program utilization, barriers, and preferences for design in rural Appalachia: differences between men and women who inject drugs. Subst Use Misuse. 2020;55(14):2268\u201377.","journal-title":"Subst Use Misuse"},{"key":"1461_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00425-9","volume":"17","author":"M V\u00e4rm\u00e5 Falk","year":"2020","unstructured":"V\u00e4rm\u00e5 Falk M, Str\u00f6mdahl S, Ekstr\u00f6m AM, et al. A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs. Harm Reduct J. 2020;17:1\u201310.","journal-title":"Harm Reduct J"},{"key":"1461_CR72","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200005010-00010","author":"ED Riley","year":"2000","unstructured":"Riley ED, Safaeian M, Strathdee SA, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. JAIDS J Acquir Immune Defic Syndr. 2000. https:\/\/doi.org\/10.1097\/00126334-200005010-00010.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"1461_CR73","doi-asserted-by":"publisher","unstructured":"Frost MC, Sweek EW, Austin EJ, et al. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S. AIDS and Behavior. 2022\/01\/01 2022;26(1):57\u201368. https:\/\/doi.org\/10.1007\/s10461-021-03332-7","DOI":"10.1007\/s10461-021-03332-7"},{"issue":"3","key":"1461_CR74","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-083983","volume":"14","author":"AM Young","year":"2024","unstructured":"Young AM, Havens JR, Cooper HL, et al. Kentucky Outreach Service Kiosk (KyOSK) study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk on HIV, HCV and overdose risk in rural Appalachia. BMJ Open. 2024;14(3):e083983.","journal-title":"BMJ Open"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01461-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01461-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01461-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:54:55Z","timestamp":1781052895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01461-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1461"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01461-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Amanda Fallin-Bennett and Alex Elswick are Co-founders of Voices of Hope.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}